Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovation showcase displays growing influence 2024-04-30 17:41
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report 2024-04-30 15:00
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) 2024-04-30 12:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
CARsgen Submitted Responses to FDA Observations 2024-04-29 20:50
Henlius Trastuzumab Receives FDA Approval in the United States 2024-04-29 20:18
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial 2024-04-29 20:00
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations 2024-04-29 19:00
Angel Yeast Publishes 2023 Corporate Social Responsibility Report 2024-04-29 19:00
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative 2024-04-29 15:31
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 2024-04-29 10:40
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC 2024-04-26 21:00
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa 2024-04-26 12:39
Hyosung TNC presents a new paradigm through sustainable bio BDO production. 2024-04-26 08:00
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints 2024-04-26 01:25
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor 2024-04-25 22:00
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil 2024-04-25 21:41
1 38 39 40 41 42 451